Antagonistic effect of EGF against TGF ßl on transformed phenotype and tropomyosin expression of human lung carcinoma A549 cells

Oncology Reports

Volumn 7, Issue 6, 2000, Pages 1323-1326

  Tada, A ^a   Kato, H ^b   Hasegawa, S ^c  

^a Chiba City Health Center   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c Chiba City Institute of Health and Environment   (Japan)

Author keywords

Epidermal growth factor; Transformation; Transforming growth factor type 1; Tropomyosin

Indexed keywords

EPIDERMAL GROWTH FACTOR; ISOPROTEIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TROPOMYOSIN;

ARTICLE; BIOSYNTHESIS; CANCER STEM CELL; CELL ADHESION; CELL CULTURE; CELL DIVISION; CELL TRANSFORMATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHENOTYPE;

CELL ADHESION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPIDERMAL GROWTH FACTOR; HUMANS; LUNG NEOPLASMS; PHENOTYPE; PROTEIN ISOFORMS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TROPOMYOSIN; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0034320257     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisingcr AC, Leppert M, Nakayama Y, White R, Smiths AMM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
2. Van der Geer P, Hunter T and Lindberg RA: Receptor proteintyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10: 251-337, 1994.
3. Hendticks M and Weintraub H: Tropomyosin is decreased in transformed cells. Proc Natl Acad Sci USA 78: 5633-5637, 1981.
4. Talbot K and Macleod AR: Novel form of non-muscle tropomyosin in human fibroblasts. J Biol Chem 253: 1137-1148, 1983.
5. Matsumura F, Lin JJC, Yamashiro-Matsumura S, Thomas GP and Topp WC: Differential expression of tropomyosin forms in the microfilaments isolated from normal and transformed rat cultured cells. J Biol Chem 258: 13954-13964, 1983.
6. Matsumura F, Yamashiro-Matsumura S and Lin JJC: Isolation and characterization of tropomyosin-containing microfilamennts from cultured cells. J Biol Chem 258: 6636-6644, 1983.
7. Lin JJC, Yamashiro-Matsumura S and Matsumura F: Microfilaments in normal and transformed cells: changes in the multiple forms of tropomyosin. Cancer Cells: 57-65, 1984.
8. Button E, Shapland C and Lawson D: Actin, its associated proteins and metastasis. Cell Motil Cytoskeleton 30: 247-251, 1995.
9. Bhattacharya B, Prasad GL, Valverius EM, Salomon DS and Cooper HL: Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res 50: 2105-2112, 1990.
10. Cooper HL, Feuerstein N, Noda M and Bassin RH: Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structually diverse retrovial oncogenes. Mol Cell Biol 5: 972-983, 1985.
11. Takenaga K, Nakamura Y and Sakiyama S: Differential expression of a tropomyosin isoform in low- and high- metastatic Lewis lung carcinoma cells. Mol Cell Biol 8: 3934-3937, 1988.
12. Takenaga K, Nakamura Y and Sakiyama S: Suppression of synthesis of tropomyosin isoform 2 in metastatic v-Ha-ras-transformed NIH3T3 cells. Biochem Biophys Res Commun 157: 1111-1116, 1988.
13. Prasad GL, Fuldner RA and Cooper HL: Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA 90: 7039-7043, 1993.
14. Takenaga K and Matsuda A: Restoration of microfilament bundle organization in v-raf-transformcd NRK cells after transduction with tropomyosin 2 cDNA. Cancer Lett 87: 47-53, 1994.
15. Braverman RH, Cooper HL, Lee H-S and Prasad GL: Antioncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. Oncogene 13: 537-545, 1996.
16. Masuda A, Takenaga K, Kondoh F, Fukami H, Utsumi K and Okayama H: Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells. Oncogene 12: 2081-2088, 1996.
17. Tada A, Kato H, Takenaga K and Hasegawa S: Transforming growth factor ß1 increases the expressions of high molecular weight tropomyosin isoforms and vinculin and suppresses the transformed phcnotypes in human lung carcinoma cells. Cancer Lett 121: 31-37, 1997.
18. Roberts AB, Anzano MA, Wakefield LM, Ruche NS, Stern DF and Sporn MB: Type ß transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82: 119-123, 1985.
19. Nakamura Y, Sakiyama S and Takenaga K: Suppression of syntheses of high molucular weight nonmuscle tropomyosins in macrophages. Cell Motil Cytoskclcton 31: 273-282, 1995.
20. Ullrich A and Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990.
21. ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nuclcotide exchange factor. Cell 73: 611-620, 1993.
22. cbl is a cytosolic adapter protein that associates with phosphoinoside 3-kinase in response to epidermal growth factor in PC12 and other cells. J Biol Chem 271: 563-567,1996.
23. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE and Stark GR: Role of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16: 369-375, 1996.
24. Stefani AL, Basso D, Panozzo MP, Greco E, Mazza S, Zancanaro F, DcFranchis G and Plebani M: Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. Pancreas 19: 362-369, 1999.
25. Locci P, Baroni T, Lilli C, Martinese D, Marinucci L, Bellocchio S, Calvitti M and Becchetti E: TGF beta and TGF alpha, antagonistic effect in vitro on extracellular matrix accumulation by chick skin fibroblasts at two distinct embryonic stages. Int J Dev Biol 43: 157-165, 1999.
26. Roberts AB, Anzano MA, Lamb LC, Smith JM and Sporn MB: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78: 5339-5343, 1981.